Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoriasis Treated with Biologics
JID, 2023.
Al-Janabi A, Eyre S, Foulkes AC, Khan AR, Dand N, Burova E, DeSilva B, Makrygeorgou, Davies E, Smith CH, Griffiths CEM, Morris AP, Warren RB; BSTOP & BADBIR Study Groups.
Read publication: JID
Related
Characteristics of "super responders" and "super nonresponders" to first biologic monotherapy for ps...
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for pa...
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective c...
0 Comments